Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 177
Filter
1.
J Coll Physicians Surg Pak ; 32(8): S107-S109, 2022 Aug.
Article in English | MEDLINE | ID: mdl-36210663

ABSTRACT

Activated charcoal, having the capacity to absorb substances with its porous surface, has been used in intoxication treatment for nearly 200 years. Although live-saving, occasionally, it can lead to complications. Because of the risk of perforation during activated charcoal therapy, the integrity of the gastrointestinal tract should be checked after the procedure. In this case report, a 27-year patient, who received activated charcoal therapy after diclofenac intoxication developed duodenal ulcer perforation and charcoal peritonitis. The present case constitutes the first report of duodenal ulcer perforation after activated charcoal therapy. It should be remembered that activated charcoal, which is widely used in intoxication treatment, may cause gastrointestinal system perforation, peritonitis, adhesion, abscess formation, organ loss within the abdomen, and prolonged hospitalization. Key Words: Activated charcoal, Intoxication, Duodenal ulcer perforation.


Subject(s)
Duodenal Ulcer , Peptic Ulcer Perforation , Peritonitis , Charcoal/therapeutic use , Diclofenac/adverse effects , Duodenal Ulcer/chemically induced , Duodenal Ulcer/complications , Humans , Peptic Ulcer Perforation/chemically induced , Peptic Ulcer Perforation/complications , Peptic Ulcer Perforation/surgery , Peritonitis/complications
2.
J Coll Physicians Surg Pak ; 32(4): S21-S23, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35633001

ABSTRACT

Peptic ulcer disease affects a large number of people around the world. Complications occur in 10-20% of patients and perforation develops in 2-14% of the cases. It can either be in the pyloric part of the stomach or in the first part of duodenum. Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs (NSAIDs) abuse and smoking are noted to be the most common risk factors in developing countries. Other risk factors are steroid abuse, post-surgery stress, burns and Zollinger-Ellison syndrome. Although small perforations can be treated conservatively but Graham patch repair is the treatment of choice. Double peptic ulcer perforation is a rare event with only a few cases reported worldwide. This patient presented with double peptic ulcer perforation in emergency due to post-surgery stress. She had cesarean section 10 days earlier with delayed recovery. Key Words: Peptic ulcer disease, Perforation, Graham patch repair, Cesarean section.


Subject(s)
Helicobacter Infections , Helicobacter pylori , Peptic Ulcer Perforation , Peptic Ulcer , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Cesarean Section/adverse effects , Female , Helicobacter Infections/complications , Humans , Peptic Ulcer Perforation/chemically induced , Peptic Ulcer Perforation/complications , Peptic Ulcer Perforation/surgery , Pregnancy
3.
Rev Esp Enferm Dig ; 114(7): 431-432, 2022 07.
Article in English | MEDLINE | ID: mdl-35137590

ABSTRACT

Juxtapyloric perforation is one of the most common digestive tract complications associated with cocaine use. We present the case of an habitual user of cocaine who goes to the Emergency Department due to epigastric pain due and intolerance of days of evolution. An endoscopic finding of a large antral ulcer with an ischemic appearance; in which it is not possible to show pylorus.


Subject(s)
Cocaine-Related Disorders , Cocaine , Duodenal Ulcer , Peptic Ulcer Perforation , Stomach Ulcer , Cocaine-Related Disorders/complications , Duodenal Ulcer/complications , Humans , Peptic Ulcer Perforation/chemically induced , Peptic Ulcer Perforation/diagnostic imaging , Peptic Ulcer Perforation/surgery , Pylorus , Stomach Ulcer/chemically induced , Stomach Ulcer/complications
4.
Stat Methods Med Res ; 28(2): 532-554, 2019 02.
Article in English | MEDLINE | ID: mdl-28936917

ABSTRACT

Robust inference of a low-dimensional parameter in a large semi-parametric model relies on external estimators of infinite-dimensional features of the distribution of the data. Typically, only one of the latter is optimized for the sake of constructing a well-behaved estimator of the low-dimensional parameter of interest. Optimizing more than one of them for the sake of achieving a better bias-variance trade-off in the estimation of the parameter of interest is the core idea driving the general template of the collaborative targeted minimum loss-based estimation procedure. The original instantiation of the collaborative targeted minimum loss-based estimation template can be presented as a greedy forward stepwise collaborative targeted minimum loss-based estimation algorithm. It does not scale well when the number p of covariates increases drastically. This motivates the introduction of a novel instantiation of the collaborative targeted minimum loss-based estimation template where the covariates are pre-ordered. Its time complexity is O(p) as opposed to the original O(p2) , a remarkable gain. We propose two pre-ordering strategies and suggest a rule of thumb to develop other meaningful strategies. Because it is usually unclear a priori which pre-ordering strategy to choose, we also introduce another instantiation called SL-C-TMLE algorithm that enables the data-driven choice of the better pre-ordering strategy given the problem at hand. Its time complexity is O(p) as well. The computational burden and relative performance of these algorithms were compared in simulation studies involving fully synthetic data or partially synthetic data based on a real world large electronic health database; and in analyses of three real, large electronic health databases. In all analyses involving electronic health databases, the greedy collaborative targeted minimum loss-based estimation algorithm is unacceptably slow. Simulation studies seem to indicate that our scalable collaborative targeted minimum loss-based estimation and SL-C-TMLE algorithms work well. All C-TMLEs are publicly available in a Julia software package.


Subject(s)
Models, Statistical , Aged , Algorithms , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Computer Simulation , Gastrointestinal Hemorrhage/chemically induced , Humans , Observational Studies as Topic , Peptic Ulcer/chemically induced , Peptic Ulcer Perforation/chemically induced , Propensity Score
5.
Asian J Surg ; 38(4): 239-41, 2015 Oct.
Article in English | MEDLINE | ID: mdl-23746944

ABSTRACT

Perforation peritonitis is the most common surgery performed in an emergency. Upper gastrointestinal tract perforation is more common than lower gastrointestinal perforation. Multiple peptic perforations in an individual are a relatively rare entity, with fewer than 10 cases reported in the literature. The factor that contributes the most for the occurrence of multiple peptic perforations is analgesic and steroid abuse. Herein, we report a rare case of double peptic perforation in a middle-aged man with history of analgesic use for 18 months.


Subject(s)
Peptic Ulcer Perforation/diagnosis , Stomach Ulcer/complications , Adult , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Humans , Male , Peptic Ulcer Perforation/chemically induced , Peptic Ulcer Perforation/surgery , Stomach Ulcer/chemically induced , Stomach Ulcer/diagnosis , Stomach Ulcer/surgery
7.
J Fr Ophtalmol ; 37(8): e125-7, 2014 Oct.
Article in French | MEDLINE | ID: mdl-24838029
8.
Indian J Pharmacol ; 45(3): 293-4, 2013.
Article in English | MEDLINE | ID: mdl-23833377

ABSTRACT

Duodenal ulcer perforation in pediatric age group is an uncommon entity; hence, it is not usually considered in the differential diagnosis of acute abdomen in these patients. It is important for the emergency physician to consider perforated peptic ulcer in the differential diagnosis of children presenting with acute abdominal pain, gastrointestinal bleeding, or shock. We report a 6½-year-old male child with thalassemia major who presented to emergency room with an acute abdomen and shock, who was subsequently found to have a perforated duodenal ulcer, probably related to use of oral chelating agent, deferasirox. Although, gastrointestinal symptoms like nausea, vomiting, and abdominal pain has been mentioned as infrequent adverse event in the scientific product information of deferasirox, in our current knowledge this is the first case report of perforated duodenal ulcer after oral deferasirox. The severity of this event justifies the reporting of this case. This patient had an atypical presentation in that there were no signs or symptoms of peptic ulcer disease before perforation and shock he was successfully managed with open surgery after initial resuscitation and stabilization of his general condition.


Subject(s)
Benzoates/adverse effects , Duodenal Ulcer/chemically induced , Iron Chelating Agents/adverse effects , Peptic Ulcer Perforation/chemically induced , Triazoles/adverse effects , Child , Deferasirox , Duodenal Ulcer/diagnosis , Humans , Male , Peptic Ulcer Perforation/diagnosis , beta-Thalassemia/drug therapy
9.
Ugeskr Laeger ; 174(39): 2308-10, 2012 Sep 24.
Article in Danish | MEDLINE | ID: mdl-23006228

ABSTRACT

Since perforated peptic ulcer is uncommon in children proton pump inhibitor prophylaxis is not routinely recommended when children are treated with high dose steroids. We describe a case of perforated ulcer in a six-year-old patient with nephrotic syndrome treated with high dose prednisolone. Initially, ulcer was not suspected due to uncharacteristic symptoms. The child developed peritoneal signs and surgery revealed a perforated peptic ulcer in the stomach. We recommend treatment with proton pump inhibitors if children, who are treated with high dose steroids develop abdominal symptoms, which can be caused by an ulcus.


Subject(s)
Glucocorticoids/adverse effects , Peptic Ulcer Perforation/chemically induced , Prednisolone/adverse effects , Stomach Ulcer/chemically induced , Child , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use , Humans , Male , Nephrotic Syndrome/drug therapy , Peptic Ulcer Perforation/complications , Peptic Ulcer Perforation/diagnostic imaging , Peptic Ulcer Perforation/therapy , Prednisolone/administration & dosage , Prednisolone/therapeutic use , Radiography , Stomach Ulcer/complications , Stomach Ulcer/diagnostic imaging , Stomach Ulcer/therapy
10.
Rev Gastroenterol Mex ; 77(3): 108-13, 2012.
Article in Spanish | MEDLINE | ID: mdl-22921209

ABSTRACT

BACKGROUND: The emergence of new synthetic drugs related to peptic ulcer perforation has been reported. Recently an increase in the use of inhaled methamphetamine has been observed and we have described an association of frequent use with peptic disease symptomatology and perforation. AIMS: To determine whether methamphetamine use is a factor related to peptic acid disease and perforation and to establish its demographic variables. MATERIAL AND METHODS: A retrospective, comparative, descriptive, and observational study was carried out through the evaluation of medical records of patients admitted to the Surgery Service with perforated ulcer, within the time frame of January 2002 to March 2005. A descriptive analysis was carried out, along with the Z test, odds ratio, confidence interval, p value and the Student's t test. RESULTS: Forty-two patients were divided into 2 groups: methamphetamine users (n=25) and nonusers (n=17). There was a statistically significant difference in relation to age, which was lower in the methamphetamine user group (38,7 years vs 58,88 years, p=0.0001). In addition, there was a trend in the user group to develop peptic ulcer perforation at earlier ages compared with the nonuser group (p=0.0001). There were no statistically significant differences between the two groups in regard to clinical presentation. CONCLUSIONS: Methamphetamine use is related to ulcer perforation in age groups of younger patients when compared with nonuser patients.


Subject(s)
Amphetamine-Related Disorders/complications , Central Nervous System Stimulants/adverse effects , Methamphetamine/adverse effects , Peptic Ulcer Perforation/chemically induced , Adult , Female , Humans , Male , Middle Aged , Peptic Ulcer Perforation/epidemiology , Retrospective Studies , Risk Factors
13.
Gastrointest Endosc ; 71(4): 663-8, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20363407
14.
Zentralbl Chir ; 135(3): 267-9, 2010 Jun.
Article in German | MEDLINE | ID: mdl-20013613

ABSTRACT

Since the 1980s the abuse of cocaine has been -associated with gastroduodenal perforations in the United States. Here, we report the case of a 28-year-old man who came to our hospital with severe abdominal pain after smoking cocaine. Physical examination revealed generalised abdominal guarding. His X-ray did not show any free intraperitoneal air. However, there was a slightly elevated white blood cell count. Upon laparoscopic exploration of the abdomen, the -patient was found to have a generalised peritonitis secondary to a perforation of the prepyloric anterior wall. The operative procedure consisted of ulcer excision and primary closure with a pyloroplasty as well as an extensive abdominal irrigation after laparotomy.


Subject(s)
Abdomen, Acute/chemically induced , Cocaine-Related Disorders/complications , Cocaine/toxicity , Heroin Dependence/complications , Heroin/toxicity , Narcotics/toxicity , Peptic Ulcer Perforation/chemically induced , Stomach Ulcer/chemically induced , Vasoconstrictor Agents/toxicity , Abdomen, Acute/diagnosis , Abdomen, Acute/surgery , Adult , Diagnosis, Differential , Humans , Laparoscopy , Male , Peptic Ulcer Perforation/diagnosis , Peptic Ulcer Perforation/surgery , Peritonitis/chemically induced , Peritonitis/diagnosis , Peritonitis/surgery , Pylorus/pathology , Pylorus/surgery , Stomach Ulcer/diagnosis , Stomach Ulcer/surgery
16.
Srp Arh Celok Lek ; 137(5-6): 282-4, 2009.
Article in Serbian | MEDLINE | ID: mdl-19594072

ABSTRACT

INTRODUCTION: Acetylsalicylic acid ingestion may cause serious gastrointestinal toxicity, in particular bleeding or perforated peptic ulcer. CASE OUTLINE: A 72-year-old male patient presented with diffuse abdominal pain, malaise, and dark stools. Several days before hospitalization, he had cerebrovascular insult and began to use acetylsalicylic acid of 100 mg per day. In physical findings a diffusely painful sensitivity of the abdomen was detected on palpation. Laboratory findings revealed hyposideremic anaemia with inflammatory syndrome. Native abdominal x-ray did not show the presence of pneumoperitoneum. Upper endoscopy of the gastric corpus and antrum revealed several ulcerations 10-11 mm in diameter covered with fibrin, with bleeding ulceration in the angulus region of the lesser gastric curvature. The bulbus was oedematous and hyperaemic with a perforated ulcer on the anterior wall. Upper central laparotomy showed a perforated duodenal bulbus. The posterior wall of the bulbus was normal, while the anterior wall was without scarring. Given the general condition of the patient and local findings, interrupted suture of the ulcer was performed with omentoplasty. Postoperative course was uneventful. A peroral diet was initiated on the 4th postoperative day, and the patient was discharged on the 8th postoperative day. CONCLUSION: Elderly people who use acetylsalicylic acid in prophylaxis should take it in lower doses, with proton pump inhibitors, especially during the first two months.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/adverse effects , Peptic Ulcer Perforation/chemically induced , Aged , Humans , Male
17.
BMC Gastroenterol ; 9: 25, 2009 Apr 20.
Article in English | MEDLINE | ID: mdl-19379513

ABSTRACT

BACKGROUND: Despite a decreasing incidence of peptic ulcer disease, most previous studies report a stabile incidence of ulcer complications. We wanted to investigate the incidence of peptic ulcer complications in Sweden before and after the introduction of the proton pump inhibitors (PPI) in 1988 and compare these data to the sales of non-steroid anti-inflammatory drugs (NSAID) and acetylsalicylic acid (ASA). METHODS: All cases of gastric and duodenal ulcer complications diagnosed in Sweden from 1974 to 2002 were identified using the National hospital discharge register. Information on sales of ASA/NSAID was obtained from the National prescription survey. RESULTS: When comparing the time-periods before and after 1988 we found a significantly lower incidence of peptic ulcer complications during the later period for both sexes (p < 0.001). Incidence rates varied from 1.5 to 7.8/100000 inhabitants/year regarding perforated peptic ulcers and from 5.2 to 40.2 regarding peptic ulcer bleeding. The number of sold daily dosages of prescribed NSAID/ASA tripled from 1975 to 2002. The number of prescribed sales to women was higher than to males. Sales of low-dose ASA also increased. The total volume of NSAID and ASA, i.e. over the counter sale and sold on prescription, increased by 28% during the same period. CONCLUSION: When comparing the periods before and after the introduction of the proton pump inhibitors we found a significant decrease in the incidence of peptic ulcer complications in the Swedish population after 1988 when PPI were introduced on the market. The cause of this decrease is most likely multifactorial, including smoking habits, NSAID consumption, prevalence of Helicobacter pylori and the introduction of PPI. Sales of prescribed NSAID/ASA increased, especially in middle-aged and elderly women. This fact seems to have had little effect on the incidence of peptic ulcer complications.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Gastrointestinal Hemorrhage/epidemiology , Peptic Ulcer Perforation/epidemiology , Peptic Ulcer/complications , Peptic Ulcer/drug therapy , Proton Pump Inhibitors/therapeutic use , Aged , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/adverse effects , Dose-Response Relationship, Drug , Female , Gastrointestinal Hemorrhage/chemically induced , Gastrointestinal Hemorrhage/etiology , Helicobacter Infections/complications , Humans , Incidence , Male , Middle Aged , Peptic Ulcer Perforation/chemically induced , Peptic Ulcer Perforation/etiology , Retrospective Studies , Smoking/adverse effects , Sweden/epidemiology
18.
Obes Surg ; 18(5): 530-4, 2008 May.
Article in English | MEDLINE | ID: mdl-18324450

ABSTRACT

BACKGROUND: Patients undergoing Roux-en-Y gastric bypass for the resolution of morbid obesity have significant medical sequelae related to their weight. One of the most common comorbid conditions is joint pain requiring the use of non-steroidal anti-inflammatory medications (NSAIDs). In addition to NSAIDs, patients may engage in behaviors such as smoking and alcohol misuse that increase the risk of long-term postoperative complications to include gastric perforation. METHODS: Data on 1,690 patients undergoing gastric bypass surgery were collected prospectively and reviewed retrospectively. RESULTS: We identified seven patients who presented to an emergency room and subsequently required emergent surgical intervention for repair of gastric perforation. Six of the seven cases involved use or abuse of NSAIDs. CONCLUSION: Important characteristics were identified including the use of NSAIDs, alcohol use, and non-compliance with routine long-term postoperative follow-up. Identifying those patients at high risk may decrease the incidence of this potentially life-threatening complication.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Gastric Bypass , Obesity, Morbid/epidemiology , Peptic Ulcer Perforation/epidemiology , Stomach Ulcer/complications , Adult , Comorbidity , Female , Humans , Male , Middle Aged , Obesity, Morbid/surgery , Peptic Ulcer Perforation/chemically induced , Peptic Ulcer Perforation/complications , Pneumoperitoneum/etiology , Stomach Ulcer/chemically induced , Stomach Ulcer/epidemiology
19.
Med J Aust ; 188(1): 56-7, 2008 Jan 07.
Article in English | MEDLINE | ID: mdl-18205567

ABSTRACT

Over a 6-month period, two patients presented to a community hospital emergency department with perforated gastric ulcers as the result of recreational misuse of over-the-counter ibuprofen-codeine preparations. Misuse of these medications appears to be an emerging cause of significant morbidity in patients with codeine addiction.


Subject(s)
Analgesics, Opioid/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Codeine/adverse effects , Ibuprofen/adverse effects , Peptic Ulcer Perforation/chemically induced , Stomach Ulcer/chemically induced , Substance-Related Disorders/complications , Abdominal Pain/etiology , Adult , Analgesics, Opioid/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Codeine/administration & dosage , Drug Combinations , Female , Humans , Ibuprofen/administration & dosage , Male , Nonprescription Drugs , Pneumoperitoneum/diagnostic imaging , Radiography
20.
Br J Clin Pharmacol ; 65(4): 565-72, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17922882

ABSTRACT

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: * Use of nonsteroidal anti-inflammatory drugs (NSAIDs) is a strong risk and prognostic factor for peptic ulcer perforation, and alternative analgesics are needed for high-risk patients. * Pain management guidelines propose tramadol as a treatment option for mild-to-moderate pain in patients at high risk of gastrointestinal side-effects, including peptic ulcer disease. * Tramadol may mask symptoms of peptic ulcer complications, yet tramadol's effect on peptic ulcer prognosis is unknown. WHAT THIS STUDY ADDS: * In this population-based study of 1271 patients hospitalized with peptic ulcer perforation, tramadol appeared to increase mortality at least as much as NSAIDs. * Among users of tramadol, alone or in combination with NSAIDs, adjusted 30-day mortality rate ratios were 2.02 [95% confidence interval (CI) 1.17, 3.48] and 1.32 (95% CI 0.89, 1.95), compared with patients who used neither tramadol nor NSAIDs. AIM: Use of nonsteroidal anti-inflammatory drugs (NSAIDs) increases risk and worsens prognosis for patients with complicated peptic ulcer disease. Therefore, patients who are at high risk of peptic ulcer often use tramadol instead of NSAIDs. Tramadol's effect on peptic ulcer prognosis is unknown. The aim was to examine mortality in the 30 days following hospitalization for perforated peptic ulcer among tramadol and NSAID users compared with non-users. METHODS: The study was based on data on reimbursed prescriptions and hospital discharge diagnoses for the 1993-2004 period, extracted from population-based healthcare databases. All patients with a first-time diagnosis of perforated peptic ulcer were identified, excluding those with previous ulcer diagnoses or antiulcer drug use. Cox regression was used to estimate 30-day mortality rate ratios for tramadol and NSAID users compared with non-users, adjusting for use of other drugs and comorbidity. RESULTS: Of 1271 patients with perforated peptic ulcers included in the study, 2.4% used tramadol only, 38.9% used NSAIDs and 7.9% used both. Thirty-day mortality was 28.7% overall and 48.4% among users of tramadol alone. Compared with the 645 patients who used neither tramadol nor NSAIDs, the adjusted mortality rate in the 30 days following hospitalization was 2.02-fold [95% confidence interval (CI) 1.17, 3.48] higher for the 31 'tramadol only' users, 1.41-fold (95% CI 1.12, 1.78) higher for the 495 NSAID users and 1.32-fold (95% CI 0.89, 1.95) higher for the 100 patients who used both drugs. CONCLUSION: Among patients hospitalized for perforated peptic ulcer, tramadol appears to increase mortality at a level comparable to NSAIDs.


Subject(s)
Analgesics, Opioid/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Duodenal Ulcer/chemically induced , Peptic Ulcer Perforation/chemically induced , Stomach Ulcer/chemically induced , Tramadol/adverse effects , Aged , Aged, 80 and over , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/immunology , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Denmark , Drug Administration Schedule , Duodenal Ulcer/mortality , Female , Humans , Male , Peptic Ulcer Perforation/mortality , Prognosis , Proportional Hazards Models , Stomach Ulcer/mortality , Survival Rate , Tramadol/administration & dosage , Tramadol/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...